Rita Nanda to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Rita Nanda has written about Dose-Response Relationship, Drug.
Connection Strength
0.037
-
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer. Invest New Drugs. 2021 10; 39(5):1348-1356.
Score: 0.037